The Healthcare Technology Report.

Anthropic and the Bill & Melinda Gates Foundation are putting $200 million toward AI tools designed for some of the world’s hardest-to-reach needs, from neglected disease research to classroom support and economic mobility. The four-year partnership combines grant funding, Claude usage credits, and technical support for programs in the U.S. and abroad, with a focus on are...

Isomorphic Labs has secured $2.1 billion in Series B funding to scale its proprietary AI drug design engine. Venture capital firm Thrive Capital led the financing round, bringing in a diverse capital base that includes existing backers Alphabet and GV alongside new institutional investors MGX, Temasek, CapitalG, and the UK Sovereign AI Fund. The company plans to deploy the ca...

Oura’s latest software update focuses on a part of wearable health that has often been under-measured: hormonal change. The company rolled out new features for hormonal birth control and menopause tracking, pairing smart ring biometrics with user-specific context around contraception, symptoms, and life stage. The updates are available globally for Oura Ring Gen3 and Oura Rin...

Olympus has signed an exclusive global distribution agreement with EndoRobotics to add robot-assisted tools to its EndoTherapy portfolio. Under the terms of the contract, Olympus secures the sole rights to market and supply the South Korean developer's therapeutic endoscopy systems worldwide. Commercialization will begin in the U.S. market, with subsequent regional product la...

Mobia Medical is entering the public markets with fresh capital for its commercial-stage medical device business. The company priced its initial public offering at $15 per share, selling 10 million shares for expected gross proceeds of $150 million. Shares began trading on the Nasdaq Global Select Market under the ticker symbol MOBI.

The transaction closed following th...